MAF1 inhibits hepatocarcinogenesis by fostering an immunostimulatory tumor microenvironment
Background The biological significance of MAF1, a tumor suppressor, in carcinogenesis and immune response of hepatocellular carcinoma (HCC) remains unreported. Understanding the underlying mechanisms by which MAF1 enhances anti-tumor immunity in HCC is crucial for developing novel immunotherapy stra...
Saved in:
Main Authors: | Di Cao, Shi-Juan Mai, Hui-yun Wang, Ge Ren, Yue-Ning Wang, Chao-Yue Sun, Haojiang Li, Yu-Feng Zhou, Mei-Yin Zhang, Shuo-Cheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/13/1/e009656.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transcriptomic landscape of Hras12V oncogene-induced hepatocarcinogenesis with gender disparity
by: Huaiyuan Di, et al.
Published: (2025-01-01) -
Genome-Wide Expression of MicroRNAs Is Regulated by DNA Methylation in Hepatocarcinogenesis
by: Jing Shen, et al.
Published: (2015-01-01) -
Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections
by: Joanna R. Wares, et al.
Published: (2015-07-01) -
Feedback loop centered on MAF1 reduces blood–brain barrier damage in sepsis-associated encephalopathy
by: Xuebiao Wei, et al.
Published: (2025-01-01) -
A thorny pathway of macrophage activating factor (GcMAF): from bench to bedside
by: A. A. Ostanin, et al.
Published: (2019-08-01)